(Q38163914)

30 August 2017

Alzheimer's as a metabolic disease (English)

1 reference

30 August 2017

0 references

Lloyd A Demetrius

1

1 reference

PubMed ID

24249045

30 August 2017

Jane Driver

series ordinal

2

1 reference

30 August 2017

19 November 2013

1 reference

30 August 2017

1 reference

30 August 2017

14

1 reference

30 August 2017

6

1 reference

30 August 2017

641-649

1 reference

https://scigraph.springernature.com/pub.10.1007/s10522-013-9479-7

30 August 2017

0 references

cites work

Senile amyloidosis: a protean manifestation of the aging process

1 reference

https://api.crossref.org/works/10.1007%2FS10522-013-9479-7

An inverse-Warburg effect and the origin of Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10522-013-9479-7

The inverse association of cancer and Alzheimer's: a bioenergetic mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10522-013-9479-7

Inverse association between cancer and Alzheimer's disease: results from the Framingham Heart Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10522-013-9479-7

Worldwide prevalence and incidence of dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10522-013-9479-7

The amyloid hypothesis for Alzheimer's disease: a critical reappraisal

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10522-013-9479-7

The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10522-013-9479-7

Epidemiology of dementia and Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10522-013-9479-7

Cell cycle markers in the hippocampus in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10522-013-9479-7

Oxidative damage is the earliest event in Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10522-013-9479-7

Neuroprotective therapeutics for Alzheimer's disease: progress and prospects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10522-013-9479-7

Neuroenergetics: calling upon astrocytes to satisfy hungry neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10522-013-9479-7

Reassessing the amyloid cascade hypothesis of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10522-013-9479-7

Cancer and neurodegeneration: between the devil and the deep blue sea.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10522-013-9479-7

Gene expression profiles of transcripts in amyloid precursor protein transgenic mice: up-regulation of mitochondrial metabolism and apoptotic genes is an early cellular change in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10522-013-9479-7

Cancer linked to Alzheimer disease but not vascular dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10522-013-9479-7

The molecular pathology of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10522-013-9479-7

Resolving controversies on the path to Alzheimer's therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10522-013-9479-7

Cancer as a metabolic disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10522-013-9479-7

Glucose metabolism and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10522-013-9479-7

Is aging part of Alzheimer's disease, or is Alzheimer's disease part of aging?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10522-013-9479-7

Inverse cancer comorbidity: a serendipitous opportunity to gain insight into CNS disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10522-013-9479-7

Understanding the Warburg effect: the metabolic requirements of cell proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10522-013-9479-7

Alzheimer disease, the two-hit hypothesis: an update

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10522-013-9479-7

10.1007/S10522-013-9479-7

21 January 2018

Identifiers

DOI

1 reference

PubMed ID

24249045

Dimensions Publication ID

30 August 2017

0 references

1 reference

PubMed ID

24249045